Oncology Research Information Exchange Network (ORIEN) Lung Cancer Study
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
AMPLIFY - D6571C00001 Duaklir USA Phase III Study
- Status
- COMPLETED
- Phase
- PHASE3
Formoterol Dose Ranging Study (ACHIEVE Duaklir USA Phase IIb)
- Status
- COMPLETED
- Phase
- PHASE2
Inhibition of Urinary Angiotensinogen and the Reduction of Blood Pressure by SGLT2 Inhibition in Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE3
Latin American Study of 24-hs Symptoms in Chronic Obstructive Pulmonary Disease (COPD) Patients; LASSYC Study
- Status
- COMPLETED
- Phase
- N/A
A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency
- Status
- COMPLETED
- Phase
- PHASE2
Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia
- Status
- TERMINATED
- Phase
- PHASE3
AZD2014 Plus Novel Anti-Cancer Agents in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study to Assess the Pharmacokinetics and Safety of Different Forms and Formulations of AZD9496 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Single Dose PD & PK Study With Two Formulations of Abediterol in Patients With Asthma
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With CSF-1R TKI (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers
- Status
- COMPLETED
- Phase
- PHASE1
PANORAMA - Real World Molecular Testing, Treatment Patterns, and Clinical Outcomes EGFR Mutation-Positive NSCLC
- Status
- COMPLETED
- Phase
- N/A
KOREA Study (Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy)
- Status
- COMPLETED
- Phase
- N/A
Intermittent Selumetinib for Uveal Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Ticagrelor in Fuwai Hospital
- Status
- UNKNOWN
- Phase
- N/A